Molecular and Biochemical Basis of Fluoroquinolones-Induced Phototoxicity-The Study of Antioxidant System in Human Melanocytes Exposed to UV-A Radiation.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Dec 2020
Historique:
received: 25 11 2020
revised: 10 12 2020
accepted: 16 12 2020
entrez: 23 12 2020
pubmed: 24 12 2020
medline: 2 4 2021
Statut: epublish

Résumé

Phototoxicity of fluoroquinolones is connected with oxidative stress induction. Lomefloxacin (8-halogenated derivative) is considered the most phototoxic fluoroquinolone and moxifloxacin (8-methoxy derivative) the least. Melanin pigment may protect cells from oxidative damage. On the other hand, fluoroquinolone-melanin binding may lead to accumulation of drugs and increase their toxicity to skin. The study aimed to examine the antioxidant defense system status in normal melanocytes treated with lomefloxacin and moxifloxacin and exposed to UV-A radiation. The obtained results demonstrated that UV-A radiation enhanced only the lomefloxacin-induced cytotoxic effect in tested cells. It was found that fluoroquinolones alone and with UV-A radiation decreased superoxide dismutase (SOD) activity and

Identifiants

pubmed: 33352719
pii: ijms21249714
doi: 10.3390/ijms21249714
pmc: PMC7765951
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antioxidants 0
Fluoroquinolones 0
Melanins 0
Catalase EC 1.11.1.6
Glutathione Peroxidase EC 1.11.1.9
Superoxide Dismutase EC 1.15.1.1
lomefloxacin L6BR2WJD8V
Moxifloxacin U188XYD42P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical University of Silesia
ID : KNW-1-037/K/9/O

Références

Postepy Hig Med Dosw (Online). 2008 Mar 26;62:118-24
pubmed: 18388851
Clin Exp Ophthalmol. 2007 Aug;35(6):566-77
pubmed: 17760640
Drug Saf. 2003;26(2):109-20
pubmed: 12534327
J Radiat Res. 2015 Mar;56(2):220-8
pubmed: 25480829
Free Radic Biol Med. 2002 Aug 1;33(3):337-49
pubmed: 12126755
Arch Toxicol. 1991;65(6):495-9
pubmed: 1656915
Pigment Cell Res. 1993 Jun;6(3):127-33
pubmed: 8234197
Postepy Dermatol Alergol. 2013 Feb;30(1):30-41
pubmed: 24278043
Photochem Photobiol Sci. 2012 Jan;11(1):155-62
pubmed: 21986862
Biomed Pharmacother. 2015 Aug;74:101-10
pubmed: 26349970
Clin Biochem. 1999 Nov;32(8):595-603
pubmed: 10638941
Antioxidants (Basel). 2019 Jun 10;8(6):
pubmed: 31185618
Eur J Pharmacol. 2011 Nov 1;669(1-3):32-7
pubmed: 21871884
J Dermatol Sci. 1997 Mar;14(3):225-32
pubmed: 9138480
Ann Clin Microbiol Antimicrob. 2016 May 23;15(1):34
pubmed: 27215369
J Invest Dermatol. 1991 Feb;96(2):255-9
pubmed: 1991986
Acta Pol Pharm. 2009 Nov-Dec;66(6):587-604
pubmed: 20050522
Eur J Nutr. 2000 Apr;39(2):53-61
pubmed: 10918985
Am Fam Physician. 2002 Feb 1;65(3):455-64
pubmed: 11858629
Chem Biol Interact. 2019 Apr 25;303:27-34
pubmed: 30768968
Photochem Photobiol. 1998 Apr;67(4):399-403
pubmed: 9559584
Eur J Pharmacol. 2010 Jan 25;626(2-3):146-53
pubmed: 19818344
Folia Biol (Praha). 2014;60(4):153-67
pubmed: 25152049
Pigment Cell Melanoma Res. 2015 Sep;28(5):520-44
pubmed: 26176788
Toxicol Res. 2015 Jun;31(2):97-104
pubmed: 26191378
Br J Dermatol. 2002 Apr;146 Suppl 61:7-10
pubmed: 11966725
Antimicrob Agents Chemother. 1993 Oct;37(10):2217-23
pubmed: 8257147
Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S144-57
pubmed: 15942881
Adv Drug Deliv Rev. 2018 Feb 15;126:23-43
pubmed: 29247767
Dermatol Clin. 2014 Jul;32(3):363-8, ix
pubmed: 24891058
Pharmazie. 2017 Mar 1;72(3):171-176
pubmed: 29442053
J Invest Dermatol. 1993 May;100(5):692-8
pubmed: 8491992
Eur Biophys J. 2015 Jul;44(5):359-65
pubmed: 25981866
J Invest Dermatol. 1991 Sep;97(3):405-9
pubmed: 1875041
Clin Dermatol. 2016 Sep-Oct;34(5):571-81
pubmed: 27638435
Pol Merkur Lekarski. 2009 Jul;27(157):44-7
pubmed: 19650429
J Invest Dermatol. 1999 Jan;112(1):13-8
pubmed: 9886257
Photochem Photobiol. 2011 Nov-Dec;87(6):1214-29
pubmed: 21770950
J Phys Chem B. 2006 Apr 6;110(13):6441-3
pubmed: 16570937
Pharmacol Rep. 2013;65(3):689-99
pubmed: 23950592
Indian J Dermatol. 2008 Jan;53(1):2-8
pubmed: 19967009
J Clin Invest. 1984 Oct;74(4):1398-403
pubmed: 6541229
Antimicrob Agents Chemother. 1992 Aug;36(8):1715-9
pubmed: 1329627

Auteurs

Justyna Kowalska (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Klaudia Banach (K)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Jakub Rok (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Artur Beberok (A)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Zuzanna Rzepka (Z)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Dorota Wrześniok (D)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH